I-Apixaban i-Intermediate CAS 545445-44-1 Ubunyulu > 98.0% (HPLC)
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili we-3-Morpholino-1- (4- (2-Oxopiperidin-1-yl) phenyl)-5,6-Dihydropyridin-2 (1H)-enye (CAS: 545445 -44-1) kunye nomgangatho ophezulu, ophakathi kwe-Apixaban (CAS: 503612-47-3).I-Ruifu Chemical inokubonelela ngenkonzo yehlabathi jikelele, ixabiso elikhuphisanayo, inkonzo egqwesileyo, encinci kunye nezixa ezininzi ezikhoyo.Thenga i-Apixaban Intermediates,Please contact: alvin@ruifuchem.com
Igama leMchiza | 3-Morpholino-1-(4-(2-Oxopiperidin-1-yl)phenyl)-5,6-Dihydropyridin-2(1H)-enye |
Izithethantonye | I-Apixaban ePhakathi 1;5,6-Dihydro-3- (4-Morpholinyl) -1-[4-(2-Oxo-1-Piperidinyl) phenyl] -2 (1H) -Pyridinone;5-Morpholin-4-yl-1-[4-(2-Oxopiperidin-1-yl) phenyl] -2,3-Dihydropyridin-6-enye;Ukungacoceki kweApixaban A |
Ubume beStokhwe | Kwi-Stock, iMveliso yoRhwebo |
Inombolo yeCAS | 545445-44-1 |
Ifomula yeemolekyuli | I-C20H25N3O3 |
Ubunzima beMolekyuli | 355.43 g/mol |
Indawo yokunyibilika | >199℃(ngoDisemba) |
Ukuxinana | 1.267 g/mL |
I-COA kunye ne-MSDS | Iyafumaneka |
Imvelaphi | Shanghai, China |
Udidi | Phakathi kwe-Apixaban (CAS: 503612-47-3) |
Uphawu | Ruifu Chemical |
Izinto | Iinkcukacha | Iziphumo |
Imbonakalo | Umgubo oMthubi oKhanya | Umgubo oMthubi oKhanya |
Ilahleko ekomisweni | <0.50% | 0.16% |
Intsalela kwi-Ignition | <0.20% | 0.07% |
Ubunyulu / Indlela yokuHlalutya | >98.0% (Ummandla weHPLC) | 99.12% |
Nakuphi na Ukungacoceki komntu | <0.50% | <0.50% |
Ukungcola ngokupheleleyo | <2.00% | 0.88% |
I-1H NMR Spectrum | Ngokungqinelana noLwakhiwo | Iyahambelana |
I-LC-MS yokuchonga | Iyahambelana | Iyahambelana |
Ukuqukumbela | Imveliso ivavanyiwe kwaye ihambelana neenkcukacha ezinikiweyo | |
Isicelo | Phakathi kwe-Apixaban (CAS: 503612-47-3) |
Umqulu:Ibhotile eFluorinated, iAluminium foil bag, 25kg/Cardboard Drum, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina isikhongozeli sivaliwe kwaye usigcine kwindawo epholileyo, eyomileyo nengena umoya kakuhle kude nezinto ezingahambelaniyo.Khusela ukukhanya kunye nokufuma.
Ukuhambisa ngenqanawe:Zisa kwihlabathi liphela ngomoya, ngeFedEx / DHL Express.Ukubonelela ngokukhawuleza nangokuthembekileyo.
Ukuthenga njani?Nceda uqhagamshelaneDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Amava Eminyaka Eli-15?Sineminyaka engaphezu kwe-15 yamava ekwenziweni nasekuthumeleni kumazwe angaphandle uluhlu olubanzi oluphezulu lwamayeza aphakathi okanye amachiza alungileyo.
Iimarike eziphambili?Thengisa kwimarike yasekhaya, eMntla Melika, eYurophu, eIndiya, eKorea, eJapan, eOstreliya, njl.
Iingenelo?Umgangatho ophezulu, ixabiso elifikelelekayo, iinkonzo zengcali kunye nenkxaso yobugcisa, ukuhanjiswa ngokukhawuleza.
UmgangathoIsiqinisekiso?Inkqubo yokulawula umgangatho ongqongqo.Izixhobo zobuchwephesha zokuhlalutya ziquka i-NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, njl.
Iisampulu?Uninzi lweemveliso zibonelela ngeesampulu zasimahla zokuvavanya umgangatho, iindleko zokuthumela kufuneka zihlawulwe ngabathengi.
Factory Audit?Uphicotho-zincwadi lwasefektri wamkelekile.Nceda wenze idinga kwangaphambili.
MOQ?Akukho MOQ.Umyalelo omncinci wamkelekile.
Ixesha lokuzisa? Ukuba ngaphakathi kwesitokhwe, ukuhanjiswa kweentsuku ezintathu kuqinisekisiwe.
Ezothutho?Nge-Express (FedEx, DHL), ngoMoya, ngoLwandle.
Amaxwebhu?Emva kwenkonzo yokuthengisa: I-COA, i-MOA, i-ROS, i-MSDS, njl.
Udibaniso lweSiko?Inokubonelela ngeenkonzo zesiko lokudibanisa ukuze zilungele iimfuno zakho zophando.
Immimiselo yokuhlawula?I-invoyisi yeProforma iya kuthunyelwa kuqala emva kokuqinisekiswa kwe-odolo, efakwe kwiinkcukacha zethu zebhanki.Intlawulo nge-T / T (i-Telex Transfer), i-PayPal, i-Western Union, njl.
I-3-Morpholino-1- (4-(2-Oxopiperidin-1-yl)phenyl)-5,6-Dihydropyridin-2 (1H)-enye (CAS: 545445-44-1) iphakathi kwe-Apixaban (CAS: 503612-47-3).
I-Apixaban luhlobo olutsha lwe-oral Xa factor inhibitor ehlanganiswe nguBristol-Myers Squibb kunye nePfizer.Igama lokurhweba yi-Eratol, luhlobo olutsha lwe-anticoagulant yomlomo.Ngokuthintela i-coagulation factor Xa, i-Apixaban inokuthintela ukuveliswa kwe-thrombin kunye ne-thrombosis.Ngo-Aprili 26, i-2007, uBristol-Myers Squibb wadibanisa izandla kunye noPfizer ukuvakalisa intsebenziswano ekuphuhliseni i-anticoagulant yomlomo entsha i-Apixaban ephethwe nguBristol-Myers Squibb njengenye indlela ephuculweyo yeWarfarin.NgoMeyi 2011, i-Apixaban yaba ngowokuqala ukuvuma ukukhuselwa kwe-venous thrombosis kwizigulane zabantu abadala ezithatha utyando olukhethiweyo lwe-hip okanye idolo kumazwe angama-27 e-EU, e-Iceland naseNorway.Ngomhla we-20 kaNovemba, i-2012, iKhomishoni yaseYurophu yavuma i-Ererto (i-Apixaban) yokuthintela i-stroke kunye ne-systemic embolism kwizigulane zabantu abadala abane-non-valvular atrial fibrillation (NVAF) kunye neengozi enye okanye ngaphezulu.Emva koko, i-Canadian Food and Drug Administration, eJapan, kunye ne-US FDA ivume i-Ererto (i-Apixaban) yokuthintela ukubetha kunye ne-systemic embolism kwizigulane zabantu abadala abane-non-valvular atrial fibrillation (NVAF) kunye nenye okanye ngaphezulu kwezinto ezinobungozi.Ngomhla we-12 ka-Apreli, i-2013, i-anticoagulant drug Eloto (ELIQUIS) (Apixaban) ngokubambisana neBristol-Myers Squibb kunye nePfizer yabhengezwa ngokusemthethweni ukuba ibhalwe eChina.